Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Däumer

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2018
Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem CellsJens Verheyen, Alexander Thielen, Nadine Lübke, et al.
The New England Journal of Medicine|August 29, 2019
Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118RNadine Lübke, Björn Jensen, Falk Hüttig, et al.
Journal of Virology|March 29, 2013
Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patientsJulia Dietz, Sven-Eric Schelhorn, Daniel Fitting, et al.
Intervirology|January 31, 2012
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledgeMartin Obermeier, Alejandro Pironti, Thomas Berg, et al.
AIDS Research and Human Retroviruses|September 18, 2024
A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected ParticipantsDirk Schürmann, Andreas Hüser, Frieder Pfäfflin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2021
Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a WeekDirk Schürmann, Deanne Jackson Rudd, Andrea Schaeffer, et al.
Plos One|August 13, 2013
HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalizationChristian Pou, Francisco M Codoñer, Alexander Thielen, et al.
Bioinformatics (Oxford, England)|September 8, 2005
Computational methods for the design of effective therapies against drug resistant HIV strainsNiko Beerenwinkel, Tobias Sing, Thomas Lengauer, et al.
Nucleic Acids Research|June 29, 2014
Full-length haplotype reconstruction to infer the structure of heterogeneous virus populationsFrancesca Di Giallonardo, Armin Töpfer, Melanie Rey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2022
Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised PatientsSmaranda Gliga, Nadine Lübke, Alexander Killer, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2018
Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem CellsJens Verheyen, Alexander Thielen, Nadine Lübke, et al.
The New England Journal of Medicine|August 29, 2019
Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118RNadine Lübke, Björn Jensen, Falk Hüttig, et al.
Journal of Virology|March 29, 2013
Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patientsJulia Dietz, Sven-Eric Schelhorn, Daniel Fitting, et al.
Intervirology|January 31, 2012
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledgeMartin Obermeier, Alejandro Pironti, Thomas Berg, et al.
AIDS Research and Human Retroviruses|September 18, 2024
A Randomized, Double-Blind, Placebo-Controlled, Short-Term Monotherapy Study of MK-6186, an HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naïve HIV-Infected ParticipantsDirk Schürmann, Andreas Hüser, Frieder Pfäfflin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2021
Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a WeekDirk Schürmann, Deanne Jackson Rudd, Andrea Schaeffer, et al.
Plos One|August 13, 2013
HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalizationChristian Pou, Francisco M Codoñer, Alexander Thielen, et al.
Bioinformatics (Oxford, England)|September 8, 2005
Computational methods for the design of effective therapies against drug resistant HIV strainsNiko Beerenwinkel, Tobias Sing, Thomas Lengauer, et al.
Nucleic Acids Research|June 29, 2014
Full-length haplotype reconstruction to infer the structure of heterogeneous virus populationsFrancesca Di Giallonardo, Armin Töpfer, Melanie Rey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2022
Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised PatientsSmaranda Gliga, Nadine Lübke, Alexander Killer, et al.
Pageof 6